Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
Multiple myeloma (MM) is an incurable B-cell malignancy. Therefore, new targets and drugs are urgently needed to improve patient outcome. Epigenetic aberrations play a crucial role in development and progression in cancer, including MM. To target these aberrations, epigenetic modulating agents, such...
Main Authors: | Elke De Bruyne, Karin Vanderkerken, Ivan Van Riet, Ken Maes, Eline Menu, Els Van Valckenborgh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/5/2/430 |
Similar Items
-
Epigenetic Therapy in Human Choriocarcinoma
by: Hisashi Narahara, et al.
Published: (2010-09-01) -
Epigenetic modulation of immunotherapy cofactors to enhance tumor response in lung cancer
by: Anuhya Kommalapati, et al.
Published: (2021-01-01) -
Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery
by: Agata Strejczek, et al.
Published: (2021-05-01) -
A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer
by: Marina Baretti, et al.
Published: (2023-04-01) -
Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA
by: Joanna Szczepanek, et al.
Published: (2023-04-01)